Stoke Therapeutics (STOK) CMO sells 14,311 shares in planned trades

Stoke Therapeutics’ Chief Medical Officer, Barry Ticho, exercised stock options and subsequently sold 14,311 shares of common stock in pre-planned transactions between March 17-19, 2026. These sales, conducted under a Rule 10b5-1 trading plan and partly to cover tax withholdings, are described as routine liquidity events rather than new signals about the stock. Following these trades, Ticho directly holds 40,702 shares of the company’s common stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin